COVID-19 负面经历与焦虑和抑郁症状之间的关联:一项基于加拿大全国代表性样本的研究。

IF 2.2 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Sandy Rao, Gina Dimitropoulos, Jeanne V A Williams, Vandad Sharifi, Mina Fahim, Amlish Munir, Andrew G M Bulloch, Scott B Patten
{"title":"COVID-19 负面经历与焦虑和抑郁症状之间的关联:一项基于加拿大全国代表性样本的研究。","authors":"Sandy Rao, Gina Dimitropoulos, Jeanne V A Williams, Vandad Sharifi, Mina Fahim, Amlish Munir, Andrew G M Bulloch, Scott B Patten","doi":"10.24095/hpcdp.44.2.03","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Amid the widespread impact of the COVID-19 pandemic, a notable increase in symptoms of anxiety and depression has become a pressing concern. This study examined the prevalence of anxiety and depression symptoms in Canada from September to December 2020, assessing demographic and socioeconomic influences, as well as the potential role of COVID-19 diagnoses and related negative experiences.</p><p><strong>Methods: </strong>Data were drawn from the Survey on COVID-19 and Mental Health by Statistics Canada, which used a two-stage sample design to gather responses from 14 689 adults across ten provinces and three territorial capitals, excluding less than 2% of the population. Data were collected through self-administered electronic questionnaires or phone interviews. Analytical techniques, such as frequencies, cross-tabulation and logistic regression, were used to assess the prevalence of anxiety and depression symptoms, the demographic characteristics of Canadians with increased anxiety and depression symptoms and the association of these symptoms with COVID-19 diagnoses and negative experiences during the pandemic.</p><p><strong>Results: </strong>The study found that 14.62% (95% CI: 13.72%-15.51%) of respondents exhibited symptoms of depression, while 12.89% (95% CI: 12.04%-13.74%) reported anxiety symptoms. No clear differences in symptom prevalence were observed between those infected by COVID-19, or those close to someone infected, compared to those without these experiences. However, there were strong associations between traditional risk factors for depressive and anxiety symptoms and negative experiences during the pandemic, such as physical health problems, loneliness and personal relationship challenges in the household.</p><p><strong>Conclusion: </strong>This study provides insight into the relationship between COVID-19 and Canadians' mental health, demonstrating an increased prevalence of anxiety and depression symptoms associated with COVID-19-related adversities and common prepandemic determinants of these symptoms. The findings suggest that mental health during the pandemic was primarily shaped by traditional determinants of depression and anxiety symptoms and also by negative experiences during the pandemic.</p>","PeriodicalId":51316,"journal":{"name":"Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice","volume":"44 2","pages":"56-65"},"PeriodicalIF":2.2000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11013027/pdf/","citationCount":"0","resultStr":"{\"title\":\"Associations between negative COVID-19 experiences and symptoms of anxiety and depression: a study based on a representative Canadian national sample.\",\"authors\":\"Sandy Rao, Gina Dimitropoulos, Jeanne V A Williams, Vandad Sharifi, Mina Fahim, Amlish Munir, Andrew G M Bulloch, Scott B Patten\",\"doi\":\"10.24095/hpcdp.44.2.03\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Amid the widespread impact of the COVID-19 pandemic, a notable increase in symptoms of anxiety and depression has become a pressing concern. This study examined the prevalence of anxiety and depression symptoms in Canada from September to December 2020, assessing demographic and socioeconomic influences, as well as the potential role of COVID-19 diagnoses and related negative experiences.</p><p><strong>Methods: </strong>Data were drawn from the Survey on COVID-19 and Mental Health by Statistics Canada, which used a two-stage sample design to gather responses from 14 689 adults across ten provinces and three territorial capitals, excluding less than 2% of the population. Data were collected through self-administered electronic questionnaires or phone interviews. Analytical techniques, such as frequencies, cross-tabulation and logistic regression, were used to assess the prevalence of anxiety and depression symptoms, the demographic characteristics of Canadians with increased anxiety and depression symptoms and the association of these symptoms with COVID-19 diagnoses and negative experiences during the pandemic.</p><p><strong>Results: </strong>The study found that 14.62% (95% CI: 13.72%-15.51%) of respondents exhibited symptoms of depression, while 12.89% (95% CI: 12.04%-13.74%) reported anxiety symptoms. No clear differences in symptom prevalence were observed between those infected by COVID-19, or those close to someone infected, compared to those without these experiences. However, there were strong associations between traditional risk factors for depressive and anxiety symptoms and negative experiences during the pandemic, such as physical health problems, loneliness and personal relationship challenges in the household.</p><p><strong>Conclusion: </strong>This study provides insight into the relationship between COVID-19 and Canadians' mental health, demonstrating an increased prevalence of anxiety and depression symptoms associated with COVID-19-related adversities and common prepandemic determinants of these symptoms. The findings suggest that mental health during the pandemic was primarily shaped by traditional determinants of depression and anxiety symptoms and also by negative experiences during the pandemic.</p>\",\"PeriodicalId\":51316,\"journal\":{\"name\":\"Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice\",\"volume\":\"44 2\",\"pages\":\"56-65\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11013027/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.24095/hpcdp.44.2.03\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Promotion and Chronic Disease Prevention in Canada-Research Policy and Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24095/hpcdp.44.2.03","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

导言:在 COVID-19 大流行的广泛影响下,焦虑和抑郁症状的显著增加已成为一个紧迫问题。本研究调查了 2020 年 9 月至 12 月期间加拿大焦虑和抑郁症状的流行情况,评估了人口和社会经济影响因素,以及 COVID-19 诊断和相关负面经历的潜在作用:数据来自加拿大统计局的 COVID-19 和心理健康调查,该调查采用两阶段抽样设计,收集了 10 个省和 3 个地区首府的 14 689 名成年人的回答,其中不包括不到 2% 的人口。数据通过自填式电子问卷或电话访谈收集。研究采用频率、交叉表法和逻辑回归等分析技术来评估焦虑和抑郁症状的发生率、焦虑和抑郁症状加重的加拿大人的人口特征,以及这些症状与 COVID-19 诊断和大流行期间的负面经历之间的关联:研究发现,14.62%(95% CI:13.72%-15.51%)的受访者有抑郁症状,12.89%(95% CI:12.04%-13.74%)的受访者有焦虑症状。受 COVID-19 感染或与感染者关系密切的受访者与没有这些经历的受访者在症状发生率方面没有明显差异。然而,抑郁和焦虑症状的传统风险因素与大流行期间的负面经历(如身体健康问题、孤独感和家庭中的人际关系挑战)之间存在密切联系:本研究深入探讨了 COVID-19 与加拿大人心理健康之间的关系,表明焦虑和抑郁症状的增加与 COVID-19 相关的逆境以及这些症状在大流行前的常见决定因素有关。研究结果表明,大流行期间的心理健康主要受抑郁和焦虑症状的传统决定因素以及大流行期间的负面经历的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Associations between negative COVID-19 experiences and symptoms of anxiety and depression: a study based on a representative Canadian national sample.

Introduction: Amid the widespread impact of the COVID-19 pandemic, a notable increase in symptoms of anxiety and depression has become a pressing concern. This study examined the prevalence of anxiety and depression symptoms in Canada from September to December 2020, assessing demographic and socioeconomic influences, as well as the potential role of COVID-19 diagnoses and related negative experiences.

Methods: Data were drawn from the Survey on COVID-19 and Mental Health by Statistics Canada, which used a two-stage sample design to gather responses from 14 689 adults across ten provinces and three territorial capitals, excluding less than 2% of the population. Data were collected through self-administered electronic questionnaires or phone interviews. Analytical techniques, such as frequencies, cross-tabulation and logistic regression, were used to assess the prevalence of anxiety and depression symptoms, the demographic characteristics of Canadians with increased anxiety and depression symptoms and the association of these symptoms with COVID-19 diagnoses and negative experiences during the pandemic.

Results: The study found that 14.62% (95% CI: 13.72%-15.51%) of respondents exhibited symptoms of depression, while 12.89% (95% CI: 12.04%-13.74%) reported anxiety symptoms. No clear differences in symptom prevalence were observed between those infected by COVID-19, or those close to someone infected, compared to those without these experiences. However, there were strong associations between traditional risk factors for depressive and anxiety symptoms and negative experiences during the pandemic, such as physical health problems, loneliness and personal relationship challenges in the household.

Conclusion: This study provides insight into the relationship between COVID-19 and Canadians' mental health, demonstrating an increased prevalence of anxiety and depression symptoms associated with COVID-19-related adversities and common prepandemic determinants of these symptoms. The findings suggest that mental health during the pandemic was primarily shaped by traditional determinants of depression and anxiety symptoms and also by negative experiences during the pandemic.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
65
审稿时长
40 weeks
期刊介绍: Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice (the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease prevention, health promotion and health equity in the areas of chronic diseases, injuries and life course health. Content includes research from fields such as public/community health, epidemiology, biostatistics, the behavioural and social sciences, and health services or economics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信